Plain-English translation of NCT06938945 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a digital symptom-tracking app can help patients with liver cancer who are receiving immunotherapy. Half of the participants will use a smartphone app to report how they're feeling each week, while the other half will receive standard care without the app. The study wants to see if regular symptom reporting helps patients understand themselves better, manage their symptoms more effectively, and get help from their doctors faster.
Doctors often don't hear about how patients are truly feeling between appointments, and patients may delay seeking help when symptoms get worse. This trial is testing whether regular digital check-ins using a smartphone app can bridge that gap and help catch problems earlier so treatment can be adjusted quickly.
You likely qualify if…
You likely don't qualify if…
If you join this study, you'll be randomly assigned to either the app group or the standard care group. If you're in the app group, you'll use your smartphone to answer questions about your symptoms once a week for the duration of the trial—the system will send you reminders, and a healthcare team member may provide advice or alerts based on your responses. If you're in the standard care group, you'll continue with your normal medical visits without using the app. You can leave the study at any time if you wish.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
China